share_log

Unicycive Announces Exclusive License, Development Agreement With Lotus For Renazorb In Republic Of Korea

Benzinga Real-time News ·  Feb 2, 2023 08:39

Develops Renazorb opportunity in new market for patients with hyperphosphatemia

Agreement includes upfront payment, royalties, and milestone payments

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment